The Effect of a Computer-Assisted Rehabilitation Program on Epilepsy Patient
NCT ID: NCT06376370
Last Updated: 2024-04-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ENROLLING_BY_INVITATION
NA
50 participants
INTERVENTIONAL
2024-04-26
2024-07-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Computer Assisted Cognitive Rehabilitation on Patients With Stroke
NCT03890159
Effects of Robot-Assisted Rehabilitation on Upper Extremity Functions in Chronic Stroke
NCT06306313
The Use of Modern Technologies in Neurorehabilitation
NCT05550987
Self Treatment With an Electronic Device for Cognitive Rehabilitation in Patients With Subacute Stroke
NCT06755437
Robotic Rehabilitation and Dual-Task Exercises in Hemiplegic Patients
NCT06709222
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Study
Patients with epilepsy who will receive a computer-assisted cognitive rehabilitation program
Application of computer-assisted cognitive rehabilitation program
Since the program will respond to the patient's specific needs, the activity may become easier or more difficult depending on the patient's performance. Epilepsy patients will be encouraged by researchers during the exercises and will be able to give feedback on progress at the end of the session. After determining the appropriate time and day for each patient in the experimental group, the intervention will continue for 6 weeks with 45-minute sessions once a week.
Control
Patients under routine follow-up of the clinic
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Application of computer-assisted cognitive rehabilitation program
Since the program will respond to the patient's specific needs, the activity may become easier or more difficult depending on the patient's performance. Epilepsy patients will be encouraged by researchers during the exercises and will be able to give feedback on progress at the end of the session. After determining the appropriate time and day for each patient in the experimental group, the intervention will continue for 6 weeks with 45-minute sessions once a week.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Having been diagnosed with epilepsy for at least 6 months
* Being between the ages of 18 and 60 (60 is the age limit for the Moxo test)
* Volunteer to provide transportation to Selçuk University Faculty of Medicine for research one day a week.
* Ability to use tools such as computer mouse and telephone
* Score 24 or more from the Mini Mental State Test
Exclusion Criteria
* Having another neurological disorder
* The individual has a transportation disability
18 Years
60 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Selcuk University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ülkü Saygılı
Assist. Prof
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
ülkü Saygili Düzova
Selçuklu, Konya, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
16.04.24/2
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.